Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

NCT00003966 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

OTHER

Sponsor class

Conditions

Veno-occlusive Disease

Interventions

DRUG: defibrotide

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]